Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Neisseria meningitidis group Y capsular polysaccharide is a linear heteropolymer composed primarily of alternating D-glucose and N-acetylneuraminic acid residues with specific glycosidic linkages. Its synthesis involves dedicated genes within the cps locus on the bacterial chromosome. This structure not only defines serogroup specificity but also underpins both pathogenesis—by protecting bacteria from host defenses—and prevention strategies through its inclusion in effective conjugate vaccines against invasive disease caused by this organism.
Vaccines induce antibody production that opsonizes bacteria for phagocytosis and complement-mediated lysis.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neisseria meningitidis capsular polysaccharide group Y.